Retraction: Genetic Polymorphism of Glucokinase on the Risk of Type 2 Diabetes and Impaired Glucose Regulation: Evidence Based on 298, 468 Subjects (PLoS ONE (2013) 8:2 (e55727) DOI: 10.1371/journal.pone.0055727);Genetic Polymorphism of Glucokinase on the Risk of Type 2 Diabetes and Impaired Glucose Regulation: Evidence Based on 298, 468 Subjects

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Fu, Da ^a   Cong, Xianling ^b   Ma, Yushui ^a   Cai, Haidong ^a   Cai, Mingxiang ^a   Li, Dan ^a   Lv, Mingli ^a   Yuan, Xueyu ^a   Huang, Yinghui ^b   Lv, Zhongwei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE;

ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLUCOKINASE GENE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE REGULATION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

EID: 84874171496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0261919     Document Type: Erratum

References (44)

1. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identified additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645.
2. McCarthy MI, (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339-2350.
3. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579-589.
4. Matschinsky FM, (1996) Banting lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45: 223-241.
5. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, et al. (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328: 697-702.
6. Gloyn AL, (2003) Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 22: 353-362.
7. Njølstad PR, Søvik O, Cuesta-Muñoz A, Bjørkhaug L, Massa O, et al. (2001) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344: 1588-1592.
8. Christesen HB, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, et al. (2002) The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes 51: 1240-1246.
9. Cuesta-Muñoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Näntö-Salonen K, et al. (2004) Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 53: 2164-2168.
10. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, et al. (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338: 226-230.
11. Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, et al. (2003) Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52: 2433-2440.
12. Vaxillaire M, Veslot J, Dina C, Proença C, Cauchi S, et al. (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57: 244-254.
13. März W, Nauck M, Hoffmann MM, Nagel D, Boehm BO, et al. (2004) G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 109: 2844-2849.
14. Rose CS, Ek J, Urhammer SA, Glümer C, Borch-Johnsen K, et al. (2005) A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54: 3026-3031.
15. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D Jr, (1996) A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Diabetes 45: 422-428.
16. Yamada K, Yuan X, Ishiyama S, Ichikawa F, Koyama KI, et al. (1997) Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant. Diabetes Care 20: 1159-1161.
17. Weedon MN, Clark VJ, Qian Y, Ben-Shlomo Y, Timpson N, et al. (2006) A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet 79: 991-1001.
18. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77-81.
19. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
20. DerSimonian R, Laird N, (1896) Meta-analysis in clinical trials. Control Clin Trial 7: 177-188.
21. Thompson SG, Sharp SJ, (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-2708.
22. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
23. Cauchi S, Ezzidi I, El Achhab Y, Mtiraoui N, Chaieb L, et al. (2012) European genetic variants associated with type 2 diabetes in North African Arabs. Diabetes Metab 38: 316-323.
24. Cho YS, Chen CH, Hu C, Long J, Ong RT, et al. (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44: 67-72.
25. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, et al. (2011) Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 43: 984-989.
26. Hu C, Zhang R, Wang C, Yu W, Lu J, et al. (2010) Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PloS One 5: e11761.
27. Murad AS, Smith GD, Lewis SJ, Cox A, Donovan JL, et al. (2010) A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study). Int J Mol Epidemiol Genet 1: 175-183.
28. Tam CH, Ho JS, Wang Y, Lee HM, Lam VK, et al. (2010) Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. PloS One 5: e11428.
29. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
30. Ezzidi I, Mtiraoui N, Cauchi S, Vaillant E, Dechaume A, et al. (2009) Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Med Genet 10: 33.
31. Reiling E, van 't Riet E, Groenewoud MJ, Welschen LM, van Hove EC, et al. (2009) Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 52: 1866-1870.
32. Qi Q, Wu Y, Li H, Loos RJ, Hu FB, et al. (2009) Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 52: 834-843.
33. Ma YC, Wang YM, (2009) Study of the correlation between the variation at -30 position of glucokinase gene promoter and type 2 diabetes. Zhongguo xian dai yi xue yuan zha zhi 19: 513-520.
34. Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, et al. (2008) The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 9: 45.
35. Holmkvist J, Almgren P, Lyssenko V, Lindgren CM, Eriksson KF, et al. (2008) Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes. Diabetes 57: 1738-1744.
36. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, et al. (2007) Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56: 685-693.
37. Bonnycastle LL, Willer CJ, Conneely KN, Jackson AU, Burrill CP, et al. (2006) Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55: 2534-2540.
38. Rissanen J, Saarinen L, Heikkinen S, Kekäläinen P, Mykkänen L, et al. (1998) Glucokinase gene islet promoter region variant (GA) at nucleotide -30 is not associated with reduced insulin secretion in Finns. Diabetes Care 21: 1194-1197.
39. Lotfi K, Sund G, Lowe R, Graham J, Landin-Olsson M, et al. (1997) The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus. Diabetes Incidence Study in Sweden (DISS). Diabetologia 40: 959-962.
40. Shimokawa K, Sakura H, Otabe S, Eto K, Kadowaki H, et al. (1994) Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 883-886.
41. Chiu KC, Go RC, Aoki M, Riggs AC, Tanizawa Y, et al. (1994) Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning. Diabetologia 37: 104-110.
42. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H, (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance: a population-based twin study. Diabetologia 42: 139-145.
43. Coutinho M, Gerstein HC, Wang Y, Yusuf S, (1999) The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240.
44. Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B, (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51: 803-807.